Dr. Jon Kim Andrus has spent the last 25 years working in the field of vaccines, immunization, and primary care. He has long-standing experience working in developing countries, beginning in 1985 with his first oversees assignment as Peace Corps Volunteer physician in Malawi, Africa, serving as the District Medical Officer in Mchinji District. Dr. Andrus has worked extensively in the areas of eradication of polio, measles, and rubella, as well as in the area of policy development for the introduction of new vaccines. Dr. Andrus currently serves as the Lead Technical Advisor for the Immunization Unit of the Pan American Health Organization (PAHO).
Dr. Andrus received degrees from Stanford University (Bachelor of Science), the University California Davis School of Medicine (Medical Doctorate), University California San Francisco School of Medicine (Family Practice Residency), and the Centers for Disease Control and Prevention (Epidemic Intelligence Service and Preventive Medicine Residency). Dr. Andrus holds faculty appointments at University California San Francisco School of Medicine, George Washington University School of Medicine, and Johns Hopkins Bloomberg School of Public Health. He has published numerous scientific articles in the fields of vaccines, immunization, and accelerated control of vaccine-preventable diseases.
Dr. Andrus' Keynote Address, "New Vaccine Introduction in Developing Countries: Perspectives from the Americas" will discuss rotavirus, pneumococcus, and human papilloma vaccines which each have the potential to prevent thousands of deaths in developing countries.
However, these developing countries must undergo a more rigorous analysis of a broader base of evidence if they are going to introduce these vaccines, which are more expensive than the traditional vaccines, into their national immunization programs. Dr. Andrus will present the partnership that has been developed in the Americas to help ensure evidence-based decisions are taken.
» Get more information on the Next Generation Vaccines Conference.
Copyright IBC Life Sciences, a part of Informa Life Sciences Group